Repeat high dose partial breast irradiation after lumpectomy for in-breast tumor recurrences following initial lumpectomy and radiotherapy - International Journal of Radiation Oncology • Biology • Physicsdoi:10.1016/S0360-3016(98)80362-3Melvin Deutsch...
since the majority of the time local recurrences happen near the lumpectomy cavity. These data suggest that this hypothesis may be true for the group of women who are candidates for partial-breast radiation," Dr Kamrava toldMedscape
WBI following lumpectomy has comparable ipsilateral recurrence rates compared to mastectomy, Vicini explained. Accelerated PBI treats the tumor bed area instead of the entire breast and reduces radiation treatment time from 3-6 weeks to 5-8 days, he noted. "The main purpose of our study was to...
ATLANTA — In a study of women with early breast cancer, outcomes with accelerated partial-breast irradiation (APBI) and traditional whole-breast irradiation (WBI) were comparable at 10 years. The women received the radiotherapy after lumpectomy. A matched-pair analysis revealed that were no signif...
Irradiation following lumpectomy has been the standard of care for breast conservation in early breast cancer for more than 20 years, replacing mastectomy... Catheryn,Yashar,Daniel,... - 《Expert Review of Obstetrics & Gynecology》 被引量: 6发表: 2009年 Partial breast radiation for early-stage...
CONCLUSIONS: Repeat lumpectomy and APBI for in-breast tumor recurrence after prior external beam radiotherapy has been delivered with acceptable outcomes, justifying a phase II multicenter trial for validation. 展开 关键词: reirradiation breast brachytherapy partial breast irradiation recurrent breast cancer...
that have been identified include physician bias, patient age and fear of radiation treatments [22]. There has been a desire therefore to identify a subset of women who may not benefit from the addition of radiation therapy after lumpectomy for early stage breast cancer; however, no such ...
Radiation therapy Oncology Partial breast irradiation 1. Introduction Breast cancer is the most common cancer in women worldwide, with a lifetime incidence of approximately 13% [1]. A remarkable progress in understanding the biology and pathology of breast cancer has been done over the past few ...
The whole breast has been the traditional target of postlumpectomy radiation in early-stage breast cancer for decades, which makes sense because radiation was first used as an alternative to the surgical whole-breast treatment of mastectomy. Accelerated partial breast irradiation (APBI) involves a sm...
More recently, survival data after a 20-year follow-up of large prospectively randomized studies have become available that definitively establish the equivalence of lumpectomy followed by whole-breast radiotherapy as compared to mastectomy (Fisher et al. 2002; Veronesi et al. 2002). However, ...